Michel, J., Frenking, J., Metzler, A., Meermeier, E., Schach, A., Thiel, V., Wagner, T., Kehl, N., Huhn, S., Brobeil, A., Müller-Tidow, C., Bergsagel, P. L., Goldschmidt, H., Einsele, H., Rasche, L., Chesi, M., Raab, M., Weinhold, N., Friedrich, M. (2025). Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy. Blood. https://doi.org/10.1182/blood-2025-3951